查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1678545

皮下避孕植入市场规模、份额、趋势分析报告：依产品、通路、地区、细分市场预测，2025-2030 年

Subdermal Contraceptive Implants Market Size, Share & Trends Analysis Report By Product (Etonogestrel Implant, Levonorgestrel Implant), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

皮下避孕植入市场的成长与趋势

根据Grand View Research, Inc.的最新报告，全球皮下避孕植入市场规模预计到2030年将达到17.4亿美元，预计2025年至2030年期间的复合年增长率为7.61%。

市面上出现了多种现代避孕药物，人们对各种避孕方法的认识不断提高，以及人均收入较高，是推动避孕皮下植入市场发展的一些主要因素。

根据古特马赫研究所统计，2014 年约有 2,000 万名女性需要公共资助的避孕服务。根据美国疾病管制与预防中心统计，2017 年，美国约有 4,690 万名女性使用至少一种避孕方法。皮下植入是女性的长期避孕方法。皮下避孕植入为聚合物胶囊或棒状物，插入皮下。孕酮以缓慢而稳定的速度释放，可提供一至五年的有效避孕效果。

公共资助的计划生育服务帮助妇女避免怀孕或计划怀孕。 2012 年，南卡罗来纳州卫生与公众服务部 (SCDHHS) 修改了产后不久植入长效可逆避孕药 (LARC) 的医疗补助付款政策。根据这项新的付款政策，服务提供者除了可以使用诊断相关群组 (DRG) 之外，还可以使用带有计划生育修饰符的 J 代码来收取插入手术费用以及子宫内避孕器或植入的费用。

植入是撒哈拉以南非洲地区妇女最广泛使用的避孕方法。这要归功于製造商、捐助者、政府和国际组织之间的官民合作关係关係，这些合作伙伴关係有助于降低商品成本并提高产品供应量。南非、马拉威和卢安达的避孕器使用率正在增加。根据 PLOS.org 报导，2016 年马拉威都市区的长效可逆避孕 (LARC) 使用率达 10.21%，农村地区的使用率达 9.66%。 2012年，一项名为「2020计划生育」（FP2020）的倡议启动，旨在确保到2020年有1.2亿女性能够获得现代避孕措施。

皮下避孕植入市场报告重点

  • 依托孕烯植入将占据市场主导地位，到 2024 年将占 64.73% 的份额。驱动因素是意外怀孕和不安全流产的增加。
  • 医院将主导市场，到 2024 年将占据 54.37% 的份额。医院为患者提供全面的环境，并提供包括检查、咨询和程序在内的广泛服务，从而推动了该领域的成长。
  • 北美皮下避孕植入物市场占据主导地位，2024 年的市占率为 64.91%。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 皮下避孕植入市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 产业挑战与机会分析
  • 皮下避孕植入市场分析工具
    • 波特的分析
    • PESTEL 分析

第 4 章 皮下避孕植入市场：依产品分類的估计与趋势分析

  • 定义和范围
  • 2024 年及 2030 年产品市场占有率分析
  • 细分仪表板
  • 2018 年至 2030 年皮下避孕植入市场（依产品划分）
    • 依托孕烯植入
    • levonorgestrel植入

第 5 章 皮下避孕植入市场：依通路进行的估计与趋势分析

  • 定义和范围
  • 2024 年及 2030 年通路市场占有率分析
  • 细分仪表板
  • 2018 年至 2030 年皮下避孕植入市场（依通路划分）
    • 医院
    • 妇科门诊
    • 社区健康中心
    • 其他的

第六章 皮下避孕植入市场：按地区分類的估计和趋势分析

  • 定义和范围
  • 2024 年及 2030 年区域市场占有率分析
  • 2024 年及 2030 年皮下避孕植入各地区市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的近期趋势及影响分析
  • 公司分类
  • 公司市场占有率分析
  • 公司热图分析
  • 战略地图
  • 公司简介
    • Merck & Co., Inc.
    • Shanghai Dahua Pharmaceutical Co., Ltd.
    • Bayer AG
    • Baxter
    • BD
    • Gerresheimer AG
    • Pfizer, Inc.
    • Novartis AG
    • SCHOTT
    • Lilly
Product Code: GVR-3-68038-848-0

Subdermal Contraceptive Implants Market Growth & Trends:

The global subdermal contraceptive implants market size is estimated to reach USD 1.74 billion by 2030, registering to grow at a CAGR of 7.61% from 2025 to 2030 according to a new report by Grand View Research, Inc. Introduction of several modern contraceptives in the market, growing awareness about various birth control methods, and high per capita income are some of the key factors driving the market for subdermal implants for birth control.

According to the Guttmacher Institute, in 2014, approximately 20 million women needed publicly funded contraceptive services. According to CDC, in 2017, nearly 46.9 million women in the U.S. were using at least one method of contraception. Subdermal implant is a long-term birth control option for women. Subdermal implants for contraception are in the form of polymer capsules or rods placed under the skin. The progestational hormone is released at a slow and stable rate, providing effective contraception for 1-5 years.

Publicly funded family planning services help women avoid or plan pregnancies. In 2012, the South Carolina Department of Health and Human Services (SCDHHS) revised the cost associated with Medicaid payment policy for immediate postpartum insertion of Long-Acting Reversible Contraception (LARC). Under this new reimbursement policy, providers are allowed to bill for the insertion procedure and the cost of an IUD or an implant, in addition to the Diagnosis Related Group (DRG) by using J-codes with a family planning modifier.

Implants are the most widely used contraceptive methods by women in sub-Saharan Africa owing to public-private partnerships between manufacturers, donors, governments, and international agencies, which helps lower commodity cost and increase product availability. Contraceptive usage has increased in South Africa, Malawi, and Rwanda. According to PLOS.org, in Malawi, the use of the Long-acting Reversible Contraception (LARC) method reached 10.21% in urban areas in 2016 and 9.66% in rural areas. In 2012, an initiative called Family Planning 2020 (FP2020) was launched to give 120 million women access to modern contraceptive methods by 2020.

Subdermal Contraceptive Implants Market Report Highlights:

  • Etonogestrel implants dominated the market and accounted for a share of 64.73% in 2024. The driving factors are rising unintended pregnancies and unsafe abortions.
  • Hospital dominated the market and accounted for a share of 54.37% in 2024. Hospitals provide a comprehensive environment for patients, offering a wide range of services including tests, consultations, and procedures, which drive segment growth.
  • North America subdermal contraceptive implants market dominated the market with a market share of 64.91% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Secondary Sources
    • 1.4.2. List of Primary Sources
    • 1.4.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Distribution Channel Outlook
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Subdermal Contraceptive Implants Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Awareness of family planning
      • 3.2.1.2. Demand for Long-Acting Reversible Contraceptives (LARCs)
      • 3.2.1.3. Technological advancements and product improvements
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Side effects and health concerns
    • 3.2.3. Industry Challenges and Opportunity Analysis
  • 3.3. Subdermal Contraceptive Implants Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Subdermal Contraceptive Implants Market: Product Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Subdermal Contraceptive Implants Market: By Product, 2018 to 2030
    • 4.4.1. Etonogestrel Implant
      • 4.4.1.1. Etonogestrel implant market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Levonorgestrel Implant
      • 4.4.2.1. Levonorgestrel implant market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Subdermal Contraceptive Implants Market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Distribution Channel Market Share Analysis, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Subdermal Contraceptive Implants Market: By Distribution Channel, 2018 to 2030
    • 5.4.1. Hospital
      • 5.4.1.1. Hospital market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Gynecology Clinics
      • 5.4.2.1. Gynecology clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Community Health Care Centers
      • 5.4.3.1. Community health care centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Subdermal Contraceptive Implants Market: Regional Estimates & Trend Analysis by Region, Product

  • 6.1. Definition and Scope
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Subdermal Contraceptive Implants Market Share, By Region, 2024 & 2030 (USD Million)
  • 6.4. North America
    • 6.4.1. North America Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. U.S. Key Country Dynamics
      • 6.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Canada Key Country Dynamics
      • 6.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Mexico Key Country Dynamics
      • 6.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. UK Key Country Dynamics
      • 6.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. U.K. Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Germany Key Country Dynamics
      • 6.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. France Key Country Dynamics
      • 6.5.4.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Italy Key Country Dynamics
      • 6.5.5.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Spain Key Country Dynamics
      • 6.5.6.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Denmark Spain Key Country Dynamics
      • 6.5.7.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Denmark Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Sweden Key Country Dynamics
      • 6.5.8.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Sweden Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Norway Key Country Dynamics
      • 6.5.9.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Norway Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. China Key Country Dynamics
      • 6.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. China Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Japan
      • 6.6.3.1. Japan Key Country Dynamics
      • 6.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. Japan Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. India Key Country Dynamics
      • 6.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. South Korea Key Country Dynamics
      • 6.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Australia Key Country Dynamics
      • 6.6.6.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Thailand Key Country Dynamics
      • 6.6.7.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Brazil Key Country Dynamics
      • 6.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Argentina Key Country Dynamics
      • 6.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Middle East and Africa (MEA)
    • 6.8.1. Middle East and Africa Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. South Africa Key Country Dynamics
      • 6.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Saudi Arabia Key Country Dynamics
      • 6.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. UAE Key Country Dynamics
      • 6.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Kuwait Key Country Dynamics
      • 6.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Market Share Analysis
  • 7.4. Company Heat Map Analysis
  • 7.5. Strategy Mapping
  • 7.6. Company Profiles
    • 7.6.1. Merck & Co., Inc.
      • 7.6.1.1. Participant's Overview
      • 7.6.1.2. Financial Performance
      • 7.6.1.3. Product Benchmarking
      • 7.6.1.4. Recent Developments
    • 7.6.2. Shanghai Dahua Pharmaceutical Co., Ltd.
      • 7.6.2.1. Participant's Overview
      • 7.6.2.2. Financial Performance
      • 7.6.2.3. Product Benchmarking
      • 7.6.2.4. Recent Developments
    • 7.6.3. Bayer AG
      • 7.6.3.1. Participant's Overview
      • 7.6.3.2. Financial Performance
      • 7.6.3.3. Product Benchmarking
      • 7.6.3.4. Recent Developments
    • 7.6.4. Baxter
      • 7.6.4.1. Participant's Overview
      • 7.6.4.2. Financial Performance
      • 7.6.4.3. Product Benchmarking
      • 7.6.4.4. Recent Developments
    • 7.6.5. BD
      • 7.6.5.1. Participant's Overview
      • 7.6.5.2. Financial Performance
      • 7.6.5.3. Product Benchmarking
      • 7.6.5.4. Recent Developments
    • 7.6.6. Gerresheimer AG
      • 7.6.6.1. Participant's Overview
      • 7.6.6.2. Financial Performance
      • 7.6.6.3. Product Benchmarking
      • 7.6.6.4. Recent Developments
    • 7.6.7. Pfizer, Inc.
      • 7.6.7.1. Participant's Overview
      • 7.6.7.2. Financial Performance
      • 7.6.7.3. Product Benchmarking
      • 7.6.7.4. Recent Developments
    • 7.6.8. Novartis AG
      • 7.6.8.1. Participant's Overview
      • 7.6.8.2. Financial Performance
      • 7.6.8.3. Product Benchmarking
      • 7.6.8.4. Recent Developments
    • 7.6.9. SCHOTT
      • 7.6.9.1. Participant's Overview
      • 7.6.9.2. Financial Performance
      • 7.6.9.3. Product Benchmarking
      • 7.6.9.4. Recent Developments
    • 7.6.10. Lilly
      • 7.6.10.1. Participant's Overview
      • 7.6.10.2. Financial Performance
      • 7.6.10.3. Product Benchmarking
      • 7.6.10.4. Recent Developments

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 4 North America subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 5 U.S. subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 7 Canada subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 8 Canada subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 Mexico subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 10 Mexico subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 Europe subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 12 Europe subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 13 UK subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 14 UK subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Germany subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 16 Germany subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 17 France subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 18 France subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 19 Italy subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 20 Italy subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 21 Spain subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 22 Spain subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 23 Denmark subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 24 Denmark subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 25 Sweden subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 26 Sweden subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 27 Norway subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 28 Norway subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 31 Japan subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 32 Japan subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 33 China subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 34 China subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 35 India subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 36 India subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Australia subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 38 Australia subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 South Korea subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 40 South Korea subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 41 Thailand subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 42 Thailand subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 43 Latin America subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 Brazil subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 46 Brazil subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 Argentina subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 48 Argentina subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 49 MEA subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 50 MEA subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 51 South Africa subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 52 South Africa subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 53 Saudi Arabia subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 54 Saudi Arabia subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 55 UAE subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 56 UAE subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 57 Kuwait subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 58 Kuwait subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Subdermal contraceptive implants market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market snapshot
  • Fig. 7 Segment snapshot (1/2)
  • Fig. 8 Segment snapshot (2/2)
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Subdermal contraceptive implants- market size and growth prospects (USD Million)
  • Fig. 11 Subdermal contraceptive implants market: industry value chain analysis
  • Fig. 12 Subdermal contraceptive implants market: market dynamics
  • Fig. 13 Subdermal contraceptive implants market: porter's analysis
  • Fig. 14 Subdermal contraceptive implants market: pestel analysis
  • Fig. 15 Subdermal contraceptive implants market share by product 2024 & 2030 (USD Million)
  • Fig. 16 Subdermal contraceptive implants market, by product: key takeaways
  • Fig. 17 Subdermal contraceptive implants market, by product: market share, 2024 & 2030
  • Fig. 18 Etonogestrel implant market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Levonorgestrel implant market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Subdermal contraceptive implants market share by distribution channel 2024 & 2030 (USD Million)
  • Fig. 21 Subdermal contraceptive implants market, by distribution channel: key takeaways
  • Fig. 22 Subdermal contraceptive implants market, by distribution channel: market share, 2024 & 2030
  • Fig. 23 Hospital market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Gynecology clinics market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Community health care centres market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Others market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Subdermal contraceptive implants market revenue, by region, 2024 & 2030 (USD Million)
  • Fig. 28 Regional marketplace: key takeaways
  • Fig. 29 Regional marketplace: key takeaways
  • Fig. 30 North america subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.s. Subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Europe subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Uk subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 France subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Italy subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Spain subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Norway subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Asia pacific subdermal contraceptive implants market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Japan subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 China subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 India subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Australia subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South korea subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Latin america subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Mea subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi arabia subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South africa subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Uae subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key company categorization
  • Fig. 59 Company market positioning
  • Fig. 60 Key company market share analysis, 2024
  • Fig. 61 Strategic framework